Daniel M. Foulkes

This study identifies FDA-approved compounds that inhibit ExoU, a virulence factor in Pseudomonas aeruginosa, and shows their efficacy in reducing corneal infection severity in multiple models.

This paper introduces FLEX, a fusion tag derived from FGF1 that enhances protein expression, solubility, and purity across different systems.

This paper introduces an ex vivo porcine corneal infection model using plumbing rings to improve antimicrobial application and assess its efficacy against Pseudomonas aeruginosa.